Recent research has revealed that astrocytes respond to an increased GFAP level after immune system diseases [3], tumors [4], trauma [5], ischemic [6] or infectious or genetic diseases [7] or neurodegenerative insult [8]. This evidence concerns the gene GFAP and hereditary disease.